Citation Impact
Citing Papers
Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase
2007 StandoutNobel
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Oxidative Stress and Antioxidant Defense
2012 Standout
Heritable forms of hypertension
2007
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.
1998
Angiotensin II and nitric oxide: a question of balance
1999
Glucocorticoid-Remediable Aldosteronism
2003
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts
2006
SYSTEMIC FAT EMBOLISM AND PULMONARY HYPERTENSION IN SICKLE CELL DISEASE
1996
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
2003 StandoutNobel
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
Free radicals, antioxidants, and nutrition
2002 Standout
Using PAC nested deletions to order contigs and microsatellite markers at the high repetitive sequence containing Npr3 gene locus
2001 StandoutNobel
The pathogenesis of cardiac fibrosis
2013 Standout
Angiotensin–Converting Enzyme Inhibition by Enalapril: A Novel Approach to Reduce Ischemia/Reperfusion Damage After Experimental Liver Transplantation
1997
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Angiotensin II-Stimulated Nitric Oxide Release from Porcine Pulmonary Endothelium Is Mediated by Angiotensin IV
1999
Primary pulmonary hypertension
1988
Primary Pulmonary Hypertension
1997 Standout
Aldosterone-Induced Inflammation in the Rat Heart
2002
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Role of oxidative stress in cardiovascular diseases
2000
Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)
1990
Primary aldosteronism: renaissance of a syndrome
2007
Flavonoids: a review of probable mechanisms of action and potential applications
2001 Standout
Prospects for the Use of Antioxidant Therapies
1995
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition
2001 StandoutNobel
8-Hydroxydeoxyguanosine in vitro: Effects of glutathione, ascorbate, and 5-aminosalicylic acid
1992
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics
1991
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Sickle-cell disease
2010 Standout
Guidelines for management of hypertension: report of the third working party of the British Hypertension Society
1999
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Antioxidant power of angiotensin‐converting enzyme inhibitors in vitro
1998
Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism
1999
Activation of apoptosis signalling pathways by reactive oxygen species
2016 Standout
Myocardial Reperfusion Injury
2007 Standout
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Potential protective role of angiotensin‐converting enzyme inhibitors captopril and enalapril against adriamycin‐induced acute cardiac and hepatic toxicity in rats
2001
Flavonoids: an overview
2016 Standout
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 Standout
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals
1998
Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training
2007
Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease
1999
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure
1993
Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients
2007 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle
2005
Reactive oxygen species in cell signaling
2000 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Cytokine-Stimulated Nitric Oxide Production in the Human Renal Proximal Tubule and Its Modulation by Natriuretic Peptides: A Novel Immunomodulatory Mechanism?
1999
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
β-blockers in congestive heart failure
1999
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Systematic evaluation of natural phenolic antioxidants from 133 Indian medicinal plants
2006 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Oxygen free radicals and congestive heart failure.
1991
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats.
1996
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide
1995
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
1999
Cellular Stress Responses: Cell Survival and Cell Death
2010
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Ischaemia-reperfusion injury
1994
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of JS McLay being referenced
Practical issues when initiating captopril therapy in chronic heart failure
1992
Oxidative Damage in Chronic Heart Failure: Protection by Captopril Through Free Radical Scavenging?
1990
Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells
1997
Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease
1990
Is random screening of value in detecting glucocorticoid-remediable aldosteronism within a hypertensive population?
2001
Cardiovascular risk in hypertension: implications of the Sheffield Table for lipid-lowering strategy
1998
The effects of indomethacin and sulindac upon the blood pressures of individuals with untreated labile or mild hypertension.
1989
Atrial Natriuretic Factor and Angiotensin Ii Stimulate Nitric Oxide Release from Human Proximal Tubular Cells
1995
Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.
1987
Captopril: a free radical scavenger.
1989